PubRank

Robin Shattock

Author PubWeight™ 33.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat Rev Microbiol 2006 3.13
2 Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu Rev Med 2008 2.81
3 Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med 2008 2.74
4 Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 2011 2.55
5 Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 2008 2.12
6 IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol 2005 2.00
7 In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr 2005 1.99
8 The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells. J Virol 2005 1.54
9 MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques. PLoS Pathog 2012 1.07
10 Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cell-associated primary HIV-1 isolates. AIDS Res Hum Retroviruses 2006 1.06
11 Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res 2010 1.04
12 Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity. J Virol 2014 0.94
13 In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate. Antiviral Res 2007 0.89
14 Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen. Vaccine 2010 0.88
15 Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 2006 0.88
16 A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions. Proteins 2007 0.87
17 DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4. PLoS One 2011 0.85
18 Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010. J Transl Med 2011 0.82
19 Microbicides 2006 conference. AIDS Res Ther 2006 0.80
20 Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr 2016 0.78
21 Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. J Transl Med 2010 0.78
22 Shaping the science of prevention. IAVI Rep 2014 0.75
23 A plea for justice for jailed medical workers. Science 2006 0.75